New evidence
A systematic review of 12 animal studies found Lactobacillus plantarum 14D consistently reduced intestinal damage after ischemia-reperfusion injury — but the evidence is still early and entirely from non-human models.
This is the first solid evidence on this specific pairing, but it comes from a small number of animal studies, so the results are intriguing but far from ready for human application.
In a meta-analysis of 12 animal experiments, probiotics — including Lactobacillus plantarum 14D — helped protect the gut from damage caused by temporary loss of blood flow followed by restoration (ischemia-reperfusion injury). The treated animals showed stronger intestinal barrier function, less inflammation, and lower oxidative stress. However, because all data come from animal models and the sample size is small, these findings should be treated as a promising early signal, not a proven human benefit.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus plantarum 14D for Reduced Intestinal Ischemia-Reperfusion Injury — treat it as an early signal until more research accumulates.
The study
Probiotics improve intestinal ischemia-reperfusion injury: a systematic review and meta-analysis.
- Systematic Review
- n = 12
- 2025-05-22
- Frontiers in medicine
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.